Company Bellevue Life Sciences Acquisition Corp.

Equities

BLAC

US0791741087

Investment Holding Companies

Market Closed - Nasdaq 04:30:00 2024-05-16 pm EDT 5-day change 1st Jan Change
10.8 USD +0.37% Intraday chart for Bellevue Life Sciences Acquisition Corp. -1.01% +2.86%

Business Summary

Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.

Managers

Managers TitleAgeSince
Chief Executive Officer 48 20-02-29
Director of Finance/CFO 50 21-08-31

Members of the board

Members of the board TitleAgeSince
Chairman 73 23-02-13
Director/Board Member 60 23-02-13
Chief Executive Officer 48 20-02-29
Director/Board Member 59 20-07-31
Director/Board Member 56 23-02-13
Director/Board Member 56 23-02-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,041,221 1,940,721 ( 48.02 %) 0 48.02 %

Shareholders

NameEquities%Valuation
1,320,500 23.48 % 14 M $
BCM Europe AG
12.09 %
680,000 12.09 % 7 M $
322,690 5.739 % 3 M $
Wolverine Asset Management LLC
5.184 %
291,505 5.184 % 3 M $
Polar Asset Management Partners, Inc.
4.624 %
260,000 4.624 % 3 M $
AQR Arbitrage LLC
4.446 %
249,995 4.446 % 3 M $
RiverNorth Capital Management LLC
4.359 %
245,115 4.359 % 3 M $
Fir Tree Capital Management LP
3.821 %
214,860 3.821 % 2 M $
Exos Asset Management LLC
3.557 %
200,000 3.557 % 2 M $
Walleye Capital LLC
2.990 %
168,128 2.990 % 2 M $
NameEquities%Valuation
Periscope Capital, Inc.
-
907,000 - 136 050 $
Highbridge Capital Management LLC
-
836,469 - 125 470 $
JPMorgan Securities LLC
-
600,000 - 90 000 $
Polar Asset Management Partners, Inc.
-
360,000 - 54 000 $
ATW SPAC Management LLC
-
311,040 - 46 656 $
Boothbay Fund Management LLC
-
311,040 - 46 656 $
RiverNorth Capital Management LLC
-
250,000 - 37 500 $
Saba Capital Management LP
-
250,000 - 37 500 $
Exos Asset Management LLC
-
200,000 - 30 000 $
Clear Street LLC
-
190,858 - 28 629 $
NameEquities%Valuation
Periscope Capital, Inc.
-
913,600 - 27 408 $
Highbridge Capital Management LLC
-
747,900 - 22 437 $
Cowen & Co. LLC
-
455,602 - 13 668 $
Polar Asset Management Partners, Inc.
-
360,000 - 10 800 $
Boothbay Fund Management LLC
-
311,040 - 9 331 $
Shaolin Capital Management LLC
-
300,000 - 9 000 $
Saba Capital Management LP
-
250,000 - 7 500 $
RiverNorth Capital Management LLC
-
250,000 - 7 500 $
Mangrove Partners
-
204,072 - 6 122 $
Gritstone Asset Management LLC
-
200,400 - 6 012 $
NameEquities%Valuation
Space Summit Capital LLC
4.417 %
400,000 4.417 % 4 M $
Terrapin Partners LLC
0.3313 %
30,000 0.3313 % 329 850 $
Clear Street LLC
0.0415 %
3,760 0.0415 % 41 341 $
Tower Research Capital LLC
0.000110 %
10 0.000110 % 110 $

Company contact information

Bellevue Life Sciences Acquisition Corp.

10900 NE 4th Street Suite 2300

98004, Bellevue

+

address Bellevue Life Sciences Acquisition Corp.(BLAC)
  1. Stock Market
  2. Equities
  3. BLAC Stock
  4. Company Bellevue Life Sciences Acquisition Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW